Less weight gain with Dovato than Biktarvy
New European HIV guidelines address sleep, obesity and breastfeeding
Hepatitis B reactivation is rare after switching from tenofovir, two European studies show
Resistance following failure of injectable cabotegravir/rilpivirine may limit future treatment options
Low-level but detectable HIV raises the risk of treatment failure, but not long-term harm
Lenacapavir PrEP ‘special cases’: young people, missed doses and drug interactions
Broadly neutralising antibodies plus immune modulator may delay HIV rebound
Injectable HIV treatment works for people with poor HIV control in Africa
Intermittent HIV treatment dosing may be a response to the funding crisis, but adolescent study raises concerns
